Thursday 21 March 2019

Reuters Health Report: Biogen, Eisai scrap Alzheimer drug trials

Reuters.com Newsletter

Biogen, Eisai scrap Alzheimer drug trials

Biogen Inc and Eisai Co Ltd said on Thursday they will discontinue two late-stage trials testing an experimental treatment for Alzheimer's disease.

Roche sues U.S. executives in fight over diabetes test strips

Roche is seeking tens of millions of dollars in damages and compensation in a U.S. lawsuit against former executives of a Utah-based company, the Swiss drugmaker's latest case targeting what it calls fraudulent schemes involving its diabetes test strips.

Jury finding upends Bayer's Roundup defense strategy: experts

Bayer AG had hoped a new trial strategy focusing jurors on scientific evidence could stem a burgeoning tide of U.S. lawsuits over its glyphosate-based weed killer Roundup, but a second jury finding on Tuesday that the product caused cancer has narrowed the company's options, some legal experts said.

Jazz Pharma's sleep disorder treatment gets FDA nod

The U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc's treatment for patients with a form of sleep disorder, the company said on Wednesday.

Congo Ebola outbreak spreads to city of Bunia

Health authorities in Democratic Republic of Congo have confirmed a case of Ebola in another city of close to 1 million people, the health ministry said on Wednesday.

With ADHD, amphetamine has double the psychosis risk of methylphenidate

(Reuters Health) - Children and young adults with attention deficit-hyperactivity disorder (ADHD) who are treated with the stimulants amphetamine or methylphenidate face a small but significant risk of developing psychosis, with amphetamine products twice as likely to spark at problem, researchers say.

U.S. jury hears more evidence as second phase of Roundup cancer trial begins

A lawyer for a man who sued Bayer AG unit Monsanto after developing cancer on Wednesday told a jury about the company's alleged efforts to influence scientists and regulators, a day after the jury found Bayer's glyphosate-based weed killer Roundup to have caused the man's disease.

FDA allows sale of certain blood pressure drugs amid shortage

The U.S. Food and Drug Administration on Wednesday said it will temporarily allow certain manufacturers to sell blood pressure medications containing specified levels of a probable cancer-causing impurity in order to maintain adequate supplies of the drug.

Study finds key details about 'punch drunk syndrome' and Alzheimer's

Scientists studying damaged brains of boxers and other sports people have found key details about a head injury-linked disease called "punch drunk syndrome" that could help the development of new diagnostics and treatments for Alzheimer's.

Zambia bans energy drink with male sex booster Viagra

Zambia banned an energy drink on Wednesday after it was shown to have been adulterated with the male sex booster Viagra, according to authorities in Ndola, the city of manufacture.

Opioid prescriptions after plastic surgery tied to long-term use

(Reuters Health) - Opioids account for more than 90 percent of the painkillers used after plastic surgery, according to a U.S. study that questions how often these addictive narcotics are necessary to ease discomfort after operations.

Related Videos

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS